Clinical Trials in Baltimore

Showing 4641-4660 of 17,842 trials

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

NCT06426004

The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Interventions will include educational elements about NPH and three layers targeting patients, Primary Care Providers, and community health workers to enhance care access. Short-term outcomes will measure referrals to specialists, while long-term outcomes will assess healthcare utilization. The study aims to identify and reduce racial disparities in NPH care access, informing intervention strategies for NPH and other surgical areas.

Normal Pressure HydrocephalusHakim Syndrome

Johns Hopkins Bloomberg School of Public Health660 participantsStarted Apr 2026

Baltimore, Maryland, United States • Baltimore, Maryland, United States

Active Not RecruitingPhase 3< 1 mile

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

NCT03562637

The GLORIA study is a Phase III, randomized, open-label study to prospectively evaluate the efficacy and safety of adagloxad simolenin (OBI 822)/OBI-821 in the adjuvant treatment of patients with high risk, early stage Globo-H Positive TNBC.

Triple Negative Breast Cancer

OBI Pharma, Inc575 participantsStarted Dec 2018

La Jolla, California, United States • San Diego, California, United States • San Francisco, California, United States +125 more locations

Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland

Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC

Find Trials by Condition in Baltimore

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Economic Incentives and vDOT for Latent Tuberculosis Infection

Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

Pediatric ACL: Understanding Treatment Options

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

A Study of SEA-CD40 Given With Other Drugs in Cancers

Adalimumab in JIA-associated Uveitis Stopping Trial

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Impairments That Affect Correct Inhaler Use in COPD

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Peru Decentralized HIV Care

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

Trauma Informed Guilt Reduction Therapy

SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma